🇩🇰 Short selling in Denmark, Q2 2023

From 3 Apr 2023 to 30 Jun 2023, 54 Denmark companies carried disclosed short positions. The quarter's highest single reading was Novozymes A/S at 8.48% on 29 Jun 2023. 2 companies appeared in the data for the first time. 3 left it. Figures are disclosed positions from official Danish FSA data.

← Q1 2023 Q3 2023 →

Cite this page

Plain

Short position data for Short selling in Denmark, Q2 2023: Danish FSA, compiled by howshorted.com, position date 30 Jun 2023. https://howshorted.com/dk/review/2023-q2/

Wikipedia

<ref>{{cite web |title=Short selling in Denmark, Q2 2023 short position data |url=https://howshorted.com/dk/review/2023-q2/ |website=HowShorted |publisher=howshorted.com (data: Danish FSA) |date=2023-06-30 |access-date=2026-10-13}}</ref>

BibTeX

@misc{howshorted-short-selling-in-denmark-q2-2023-2023-06-30,
  title        = {Short selling in Denmark, Q2 2023 short position data},
  author       = {{HowShorted}},
  howpublished = {\url{https://howshorted.com/dk/review/2023-q2/}},
  note         = {Data: Danish FSA, position date 30 Jun 2023; accessed 2026-10-13},
  year         = {2023}
}

Biggest rises of the quarter

Novozymes A/S+2.86pp to 8.30%
Netcompany Group A/S+2.33pp to 8.34%
ChemoMetec A/S+2.19pp to 3.46%
Pandora A/S+1.93pp to 4.47%
Noble Corporation Plc+1.86pp to 3.47%

Biggest falls of the quarter

FLSmidth & Co. A/S−3.61pp to 4.13%
Chr. Hansen Holding A/S−1.06pp to 1.08%
Ambu A/S−1.05pp to 6.22%
SimCorp A/S−0.71pp to 0.60%
GN Store Nord A/S−0.53pp to 3.39%

Changes compare each company's last figure of the quarter with its first; companies with a single publication day in the quarter are counted but not ranked. Where disclosure thresholds apply the figures are floors, not a census. Nothing here is investment advice.